PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+15.38%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.97B
AUM Growth
+$821M
(+20%)
Cap. Flow
+$393M
Cap. Flow
% of AUM
7.9%
Top 10 Holdings %
Top 10 Hldgs %
46.8%
Holding
90
New
21
Increased
21
Reduced
16
Closed
29
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$400M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$263M |
| 3 |
AGN
Allergan plc
AGN
|
$188M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$129M |
| 5 |
Valero Energy
VLO
|
$120M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$195M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
PARA
Paramount Global Class B
PARA
|
$107M |
| 4 |
Dollar General
DG
|
$106M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
$106M |
Sector Composition
| 1 | Healthcare | 39.83% |
| 2 | Communication Services | 12.01% |
| 3 | Real Estate | 9.47% |
| 4 | Energy | 7.24% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNT
26
DELISTED
HEALTH NET INC
HNT
| $73.5M | 1.48% |
2,477,835
+1,440,056
| +139% | +$42.7M |
|
|
27
Thermo Fisher Scientific
TMO
$183B
| $71.3M | 1.43% |
640,428
-1,748,818
| -73% | -$195M |
|
28
CME Group
CME
$96.8B
| $71M | 1.43% |
+905,252
| New | +$71M |
|
29
Coterra Energy
CTRA
$18.5B
| $67.7M | 1.36% |
+1,747,597
| New | +$67.7M |
|
30
Baidu
BIDU
$33.7B
| $60.9M | 1.22% |
342,395
-368,004
| -52% | -$65.5M |
|
31
Marathon Petroleum
MPC
$54.5B
| $55M | 1.11% |
+1,198,944
| New | +$55M |
|
|
MHFI
32
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $52.1M | 1.05% |
+666,475
| New | +$52.1M |
|
|
AGN
33
DELISTED
ALLERGAN INC
AGN
| $50.1M | 1.01% |
+450,950
| New | +$50.1M |
|
|
PARA
34
DELISTED
Paramount Global Class B
PARA
| $41.5M | 0.83% |
650,968
-1,684,644
| -72% | -$107M |
|
|
AUXL
35
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $40.3M | 0.81% |
1,943,672
+632,655
| +48% | +$13.1M |
|
36
Netflix
NFLX
$534B
| $39.9M | 0.8% |
758,667
+8,897
| +1% | +$468K |
|
37
Tenet Healthcare
THC
$16.8B
| $39.4M | 0.79% |
935,335
+474,608
| +103% | +$20M |
|
38
Workday
WDAY
$61.4B
| $35.3M | 0.71% |
+424,785
| New | +$35.3M |
|
|
KYTH
39
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $31.1M | 0.62% |
831,840
+63,948
| +8% | +$2.39M |
|
|
OREX
40
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $28.4M | 0.57% |
504,712
+146,378
| +41% | +$8.24M |
|
|
RPRX
41
DELISTED
Repros Therapeutics Inc.
RPRX
| $28.2M | 0.57% |
1,540,091
+788,300
| +105% | +$14.4M |
|
42
Pfizer
PFE
$140B
| $25.6M | 0.51% |
880,188
-2,758,675
| -76% | -$80.2M |
|
43
Cooper Companies
COO
$13.3B
| $23.7M | 0.48% |
764,612
+386,444
| +102% | +$12M |
|
44
Karyopharm Therapeutics
KPTI
$60M
| $19.8M | 0.4% |
+59,301
| New | +$19.8M |
|
45
Bruker
BRKR
$4.47B
| $19.5M | 0.39% |
988,190
-164,914
| -14% | -$3.26M |
|
46
McKesson
MCK
$86.4B
| $18.9M | 0.38% |
117,117
+7,609
| +7% | +$1.23M |
|
|
ANAC
47
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $17.7M | 0.36% |
+1,055,014
| New | +$17.7M |
|
48
Humana
HUM
$37.5B
| $13.7M | 0.27% |
132,430
+7,609
| +6% | +$785K |
|
49
Regeneron Pharmaceuticals
REGN
$60.1B
| $13.4M | 0.27% |
48,771
-194,151
| -80% | -$53.4M |
|
50
Illumina
ILMN
$15.1B
| $10.4M | 0.21% |
+96,713
| New | +$10.4M |
|